Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17253142 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Ribavirin Dose Optimization for the Treatment of Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Drug: Peg-interferon alpha-2a, Ribavirin

Indicates status has not been verified in more than two years